Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Citicoline improves cognitive impairment in animals and elderly subjects

July 4, 1997

CRF modulator introduced in Italy

July 4, 1997

CCK-B antagonist is not effective in anxiety disorders

July 4, 1997

Etifoxine compared to buspirone for adjustment disorder with anxiety

July 4, 1997

Guilford presents prototype presynaptic glutamate blocker

July 4, 1997

PARS inhibitors under development by Guilford for stroke

July 4, 1997

Guilford's neuroimmunophilin ligand program

July 4, 1997

Selective 5-HT1D receptor agonist active in two migraine models

July 4, 1997

FDA approves Mirapex for the treatment of Parkinson's disease

July 3, 1997

CoCensys reports on phase II trial with ganaxolone

July 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...